# ProQR Therapeutics (PRQR) — Earnings

PRQR · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/prqr/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q3 2025 |
| Period end | Sep 30, 2025 |
| EPS actual | −$0.12 |
| EPS estimate | −$0.12 |
| EPS surprise | +0.85% |
| Revenue surprise | −42.86% |
| Revenue | $3.4M |
| Revenue estimate | $5.9M |
| Reported | Nov 6, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1612940/000110465925107349/prqr-20250930x6k.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q3 2025 | Nov 6, 2025 | −$0.12 | −$0.12 | 0.85% | $5.9M | $3.4M |
| Q2 2025 | Aug 7, 2025 | −$0.14 | −$0.14 | 0.00% | $4.5M | $4.5M |
| Q1 2025 | May 8, 2025 | −$0.10 | −$0.11 | -7.77% | $5.7M | $4.9M |
| Q4 2024 | Mar 13, 2025 | −$0.10 | −$0.09 | 2.92% | $5.2M | $4.2M |
| Q3 2024 | Nov 7, 2024 | −$0.12 | −$0.11 | 5.68% | $12.3M | $4.3M |
| Q2 2024 | Aug 8, 2024 | −$0.13 | −$0.03 | 75.97% | $12.3M | $6.8M |
| Q1 2024 | May 9, 2024 | −$0.12 | −$0.10 | 18.13% | $2.8M | $4.8M |
| Q4 2023 | Mar 13, 2024 | $0.02 | −$0.08 | -513.37% | $17.4M | $6.8M |
| Q3 2023 | Nov 7, 2023 | −$0.09 | −$0.07 | 18.32% | $4.9M | $1.4M |
| Q2 2023 | Aug 3, 2023 | −$0.12 | −$0.11 | 9.83% | $1.3M | $1.3M |
| Q1 2023 | May 16, 2023 | −$0.13 | −$0.12 | 6.29% | $1.4M | $709,895.55 |
| Q4 2022 | Mar 29, 2023 | −$0.20 | −$0.17 | 13.23% | $1.0M | $1.4M |
| Q3 2022 | Nov 9, 2022 | −$0.21 | −$0.33 | -60.89% | $822,204.01 | $936,908.68 |
| Q2 2022 | Aug 4, 2022 | −$0.22 | −$0.22 | 1.70% | $905,276.02 | $1.1M |
| Q1 2022 | May 5, 2022 | −$0.26 | −$0.22 | 15.70% | $888,194.49 | $1.4M |
| Q4 2021 | Feb 24, 2022 | −$0.25 | −$0.30 | -17.82% | $857,900.64 | $271,656.96 |
| Q3 2021 | Nov 4, 2021 | −$0.24 | −$0.25 | -6.92% | $272,298.96 | $1.0M |
| Q2 2021 | Aug 5, 2021 | −$0.25 | −$0.28 | -12.98% | $227,424.90 | $288,173.84 |
| Q1 2021 | May 6, 2021 | −$0.29 | −$0.29 | -2.76% | $532,022.80 | $117,529.94 |
| Q4 2020 | Feb 25, 2021 | −$0.30 | −$0.32 | -6.46% | $169,294.04 | $300,282.40 |

## Frequently Asked Questions

### When did ProQR Therapeutics (PRQR) last report earnings?

ProQR Therapeutics last reported on Nov 6, 2025, covering fiscal Q3 2025.

### Did PRQR beat earnings estimates?

Yes. ProQR Therapeutics reported EPS of −$0.12 for Q3 2025 against a −$0.12 estimate — a 0.85% beat.

### How much revenue did PRQR report last quarter?

ProQR Therapeutics reported $3.4M in revenue for Q3 2025, against a consensus estimate of $5.9M.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).